Category Pharmaceuticals and Biotech
Biohacking: Industry Disruptor, Social Movement Gaining Ground
Changes Expected in Healthcare, Tech, Wellness, and Beauty Industries Within 5 years
Baylor Genetics Launches Clinical Whole Genome Sequencing
CaryRx Aims to Uberize Pharmacies With the Launch of Their Mobile First Enterprise Pharmacy Platform
Enabling any pharmacy to modernize with a feature-rich HIPAA compliant cloud-based pharmacy platform
Lotus Clinical Research Announces the Addition of Robert Dworkin, PhD as Director, Chronic Pain Research
Robert Dworkin, Ph.D. Joins Lotus Clinical Research as Director, Chronic Pain Research to lead Lotus' chronic pain research programs
KARMET Study Begins Enrollment
Helping Patients Set Healthy Goals for the New Year
VMS BioMarketing Clinical Educator Teresita Buenrostro shares how to help patients improve self-management of chronic illnesses
Growing Skin in the Lab for the Treatment of Advanced Wounds
IDTechEx Research outlines the use of living therapies in the care of advanced wounds
Cutting Through the Industry 4.0 Paradigm: It's Not About Big Data, but How to Use Your Data, New Webinar Hosted by Xtalks
The life science industry has always been steps ahead when it comes to data collection and analysis. It's possible to argue it has been embracing 'Industry 4.0' methodology before the term existed. However, companies have also been aware of the pitfalls of 'big data' for over 40 years.
First Light Biosciences Develops Rapid Test for C. Difficile Toxin B. in Stool Samples
Results of Technical Study Presented at ASM Microbe 2018
Recent Technological Advancements in Medical Communication, New Webinar Hosted by Xtalks
Join this webinar for a discussion of the most common medical communications business challenges and potential solutions. This event will also feature a live demonstration of how patient-centric medical communications technology can be leveraged to streamline and optimize medical inquiry fulfillment, adverse event reporting and product complaint management.
Upcoming Xtalks Webinar: Clinical Supply Planning Optimization
First Light Biosciences Announces Funding From Biomedical Advanced Research and Development Authority (BARDA)
A contract extension representing $10.7 million over two years
Purchase Power is Back in the Hands of Independent Pharmacies
Members Standing Together in Fighting Price Hikes
Dr. Bob Raffa Joins Bridge Therapeutics' Scientific Advisory Board Bringing Decades of Research and Experience
Pharmaceutical startup Bridge Therapeutics announces the addition of Dr. Bob Raffa as its newest Scientific Advisory Board member.
Latest Biologic Launch in Psoriasis, UCB's Cimzia, Having a Tough Time Getting Traction, But Developing a Presence in Dermatology May Lay Foundation for Bimekizumab in the Future
Janssen's Tremfya continues to post gains, but may soon face competition as Sun Dermatology readies for the launch of Ilumya (tildrakizumab), the second IL-23 inhibitor to be introduced in the U.S. market, according to a new report from Spherix Global Insights